Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2026-01-14 @ 4:04 AM
Study NCT ID:
NCT03510832
Status:
UNKNOWN
Last Update Posted:
2018-04-27
First Post:
2018-03-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Antithrombotic STrategies in STEMI Patients in China
Sponsor:
Qilu Hospital of Shandong University
Organization:
Study Overview
Official Title:
Evaluation of Antithrombotic STrategies in STEMI Patients in China
Status:
UNKNOWN
Status Verified Date:
2018-03
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EAST-STEMI
Brief Summary:
EAST-STEMI is the first perspective, multicenter, large-scale registry focusing on the evaluation of real-world medical quality (especially PCI quality) and antithrombotic strategies in STEMI patients undergoing emergent PCI in a regional representative sample in China with 2 years follow-up. Clinical decision support tools (including ischemic score, bleeding score, etc) will be developed and validated based on the database. Novel biomarkers to predict the prognosis and to support risk stratification will be explored by using the blood samples.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: